Hyaluronan and Syndecan‐1: Linking Glycocalyx Degradation to Development and Progression of Heart Failure With Preserved Ejection Fraction

Background Heart failure with preserved ejection fraction (HFpEF) is characterized by chronic low‐grade inflammation, which influences endothelial function, affecting glycocalyx integrity, barrier permeability, and cell adhesion. The role of endothelial glycocalyx shedding in the onset and progressi...

Whakaahuatanga katoa

Ngā taipitopito rārangi puna kōrero

Ngā kaituhi matua:	Estela Rocha‐Oliveira, Jeremy Lagrange, Mohammad Jahangiri, Philippe Guerci, Guillaume Baudry, Nathalie Mercier, Luca Monzo, Céline Leroy, Zohra Lamiral, Adelino F. Leite‐Moreira, Faiez Zannad, Joao Pedro Ferreira, Francisco Vasques‐Nóvoa, Nicolas Girerd
Hōputu:	Artigo
Reo:	Inglês
I whakaputaina:	Wiley 2026-03-01
Rangatū:	Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Ngā marau:	glycocalyx heart failure heart failure with preserved ejection fraction hyaluronan sydecan‐1
Urunga tuihono:	https://www.ahajournals.org/doi/10.1161/JAHA.125.044788
Ngā Tūtohu:	Tāpirihia he Tūtohu Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!